Catalent Announces New Sales Leadership Appointments

Catalent Announces New Sales Leadership Appointments to Development and Clinical Services Business

Somerset, NJ, April 14, 2011 - Catalent Pharma Solutions, a leading provider of pharmaceutical services from drug and biologic development to delivery technologies to supply solutions, has announced three new appointments to its Development and Clinical Services business unit.  Paul Wituschek has joined as the Vice President of Sales for the Development and Clinical Services business unit.  Sven Lee will lead the Biologics sales team as the Vice President of Business Development.  Dr. Paul Ingram is appointed to the newly created role of European Sales Director for Clinical Supply Services.  Catalent is continuing to invest in building strong customer focus through the addition of these three sales veterans with outstanding, specialized industry experience.

Catalent’s Development and Clinical Services business was formed to strengthen Catalent’s services and commitment to drug development. “Our advanced technologies (like Optiform™ and GPEx®), technical expertise and broad capabilities enable us to provide innovative solutions to our customers,” commented Scott Houlton, President of Catalent’s Development and Clinical Services business. “As part of our mission to reliably supply our customers with the best services, I am excited to expand our sales leadership.  The growth we are experiencing with our customers allows us to continue to strengthen our expertise to help them deliver better treatments.”

Mr. Wituschek comes to Catalent with more than twenty-five years of experience working in domestic and international sales, marketing and management.  Prior to joining Catalent, Mr. Wituschek worked as the Global Sales and Marketing Director and served as a member of the Board of Directors for Penn Pharmaceutical Services, Ltd., a global contract development and manufacturing organization based in the United Kingdom.  He has also served as the Global Sales Director and was a member of the Corporate Leadership Team for Wolters Kluwer Health – Pharma Solutions Division where he led a global sales team to record growth and profits.

Mr. Lee brings to Catalent eighteen years of experience in professional sales, marketing and commercialization, with experience in the biotech industry.  He has extensive experience in developing global strategic and tactical plans for new product launches, including biologic technology, neurology, cardiology and rheumatology.  Prior to joining Catalent, Mr. Lee served as the Director of Business Development of North America for Crucell Holland and previously held sales roles with Biogen Idec and Sanofi Winthrop Pharmaceuticals.

Dr. Ingram joins Catalent Pharma Solutions with 15 years experience in leading sales and project management within the clinical supplies industry. Dr. Ingram was most recently with Bilcare Global Clinical Supplies as European Vice President and held prior roles with Fisher Clinical Services, Aptuit, Quintiles and Bio-Images. 
For more information about Catalent’s development and clinical supply services, visit

About Catalent

From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 8,000 people at 24 facilities worldwide and in fiscal year 2010 generated more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, NJ.

more products. better treatments. reliably supplied.™